Atlas Venture Fund IX, L.P., Ten Percent Owner at Intellia Therapeutics, holds 2.95M shares in Surface Oncology (Ticker: SURF), holds 3.36M shares in Cogent Biosciences (Ticker: COGT), holds 3.73M shares in Intellia Therapeutics (Ticker: NTLA). Most recently, Atlas Venture Fund IX, L.P. Sold ― shares of Surface Oncology on Dec 21, 2020 for an estimated value of 30.77M.